IM Cannabis (IMCC) Change in Account Payables (2020 - 2026)
IM Cannabis (IMCC) posted quarterly Change in Account Payables of -$1.9 million for Q1 2026, down 152.61% year-over-year from $3.7 million in Q1 2025, and down 147.83% quarter-over-quarter from $4.0 million in Q4 2025.
IM Cannabis (IMCC) Change in Account Payables (2020 - 2026) Analysis & Trends
IM Cannabis' Change in Account Payables history runs 7 years deep, the most recent figure standing at -$1.9 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 152.61% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at -$4.5 million (down 150.5% YoY), while the FY2025 annual figure was $1.2 million, down 78.25% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$1.9 million, down from $4.0 million in the prior quarter.
- The five-year high for Change in Account Payables was $4.9 million in Q2 2024, with the low at -$4.5 million in Q1 2023.
- The 5-year median for Change in Account Payables is $702018.7 (2023), against an average of $533640.1.
- The sharpest annual moves came in 2023 and 2024: Change in Account Payables tumbled 337.33% in 2023, then soared 658.05% in 2024.
- IM Cannabis' Change in Account Payables stood at $2.4 million in 2022, then plunged by 144.17% to -$1.1 million in 2023, then slumped by 85.34% to -$2.0 million in 2024, then soared by 305.23% to $4.0 million in 2025, then tumbled by 147.83% to -$1.9 million in 2026.
- Business Quant data shows IMCC's Change in Account Payables at -$1.9 million in Q1 2026, $4.0 million in Q4 2025, and -$3.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | IM Cannabis | 549,631.99 | -619,338.18 | 1.09 Mn | -183,623.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -183,623.02 |
| Jun 30, 2026 | -183,623.02 |
| Mar 31, 2026 | -1.93 Mn |
| Mar 31, 2026 | -1.93 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Dec 31, 2025 | 4.04 Mn |
| Sep 30, 2025 | -3.49 Mn |
| Sep 30, 2025 | -3.49 Mn |
| Jun 30, 2025 | -3.14 Mn |
| Jun 30, 2025 | -3.14 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Mar 31, 2025 | 3.67 Mn |
| Dec 31, 2024 | -1.97 Mn |
| Dec 31, 2024 | -1.97 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 4.86 Mn |
| Jun 30, 2024 | 4.86 Mn |
| Mar 31, 2024 | 492,021.06 |
| Mar 31, 2024 | 492,021.06 |